RxDoctor Payments Data

Mark Linzer, DPM

Foot & Ankle Surgery · Hanover, MDNPI 1083978282

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 45.2% of the total. Among foot & ankle surgery clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,858in general payments, 2019–2025

Across 119 payments — averaging $175.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$9K
  • Smith+Nephew$5K
  • Supreme Orthopedic Systems, LLC$3K
  • Stryker$1K
  • Flower Orthopedics Coporation$959
  • Zimmer Biomet$282
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$3,75018%
  • Speaking & faculty fees$2,00010%
  • Travel & lodging$2,21611%
  • Food & beverage$4,54422%
  • Education$8,34740%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,858 in reported general payments places this provider in the 90th percentile of 182 foot & ankle surgery providers in Maryland.

See all foot & ankle surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$123,009
Medicare patients
410
Services billed
1,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox44$1,174
Linezolid13$610
Meloxicam56$227
Oxycodone Hcl36$158
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$88
Methylprednisolone16$85
Cephalexin16$39

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Hanover

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →